Questionnaire

1. Above what level is lipoprotein(a) associated with a high risk of atherosclerotic cardiovascular disease?

2. The effect of finerenone on lowering all cause death and CV events has been shown in a meta-analysis to be sustained across the cardio-metabolic renal disease spectrum.

3. Once-weekly semaglutide in patient’s with symptomatic PAD and diabetes improved walking distance in the STRIDE trial by:

4. Low-dose colchicine’s effect on plaque progression resulted in a decrease in:

5. Continued clopidogrel monotherapy compared to aspirin monotherapy after the standard duration of DAPT post-PCI reduced the risk of MI and stroke by:

6. The proportion of positive bias of the Pulse Oximeter was higher in patients with dark skin pigment, potentially resulting in missing patients with dangerously low oxygen saturation.

7. Early TAVR compared to clinical surveillance in patients with asymptomatic severe aortic stenosis resulted in lower hospitalisation for a CV event of:

8. The EVOLUT trial of TAVR versus surgical replacement (SAVR) showed that:

9. In the POST-MI LV thrombus trial rivaroxaban plus DAPT or warfarin plus DAPT resulted in:

10. The Trilogy valve introduced for patients with aortic regurgitation showed a success rate of: